Highlights in gastro-intestinal cancer
Bron
Belgian journal of medical oncology - ISSN 1784-7141-12 (2018) p. 182-188
Phase I study of mosperafenib, a novel paradox breaker B-Raf proto-oncogene serine/threonine kinase (BRAF) inhibitor, in patients with BRAF V600-mutant solid tumors
Bron
Journal of clinical oncology - ISSN 0732-183X-44:14 (2026) p. 1337-1348
Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns
Bron
Cancer immunology and immunotherapy - ISSN 0340-7004-75:4 (2026) p. 1-17
Erdafitinib in patients with FGFR-altered advanced or metastatic cholangiocarcinoma
Bron
Clinical cancer research - ISSN 1078-0432-32:6 (2026) p. 1136-1144
Beamion PANTUMOR-1 : rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors
Bron
Future oncology - ISSN 1479-6694-22:7 (2026) p. 795-803